Cite
HARVARD Citation
Chang, Y. et al. (n.d.). Cardiovascular risks associated with second‐line oral antidiabetic agents added to metformin in patients with Type 2 diabetes: a nationwide cohort study. Diabetic medicine. 32 (11), pp. 1460-1469. [Online].